Clusterstock  Jan 18  Comment 
In drug development, the typical trajectory for a small biotech company is to develop a drug, then find a big-pharma partner to help fund trials and get the drug onto the market if it gets approved.  But a partnership announced today is...
FiercePharma  Jan 13  Comment 
FiercePharmaAsia: Takeda’s $5.2B deal for Ariad and $125M with Maverick, Valeant’s $820M Dendreon sell to Chinese company, and more aliu Fri, 01/13/2017 - 08:26
Reuters  Jan 10  Comment 
* If deal is terminated by co, to enter definitive agreement with respect to superior proposal, co to pay termination fee of $169 million Source text - http://bit.ly/2ido9QF Further company...
Yahoo  Jan 10  Comment 
Japan's Takeda Pharmaceutical Co flagged its appetite for fresh acquisitions to bolster its drug portfolio after agreeing on Monday to acquire cancer drug maker Ariad Pharmaceuticals (ARIA.O) in a $5.20 billion deal. Pfizer Inc (PFE.N) agreed in...
Motley Fool  Jan 9  Comment 
Ariad Pharmaceuticals finally finds a suitor.
Wall Street Journal  Jan 9  Comment 
Takeda Pharmaceutical’s proposed acquisition of Ariad Pharmaceuticals for about $4.7 billion could boost valuations as buyers regain confidence in ability to raise prices.
New York Times  Jan 9  Comment 
Japan's Takeda Pharmaceutical Co Ltd said it would buy cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion, to beef up its oncology pipeline.


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki